What is CANF's dilution risk score?

CANF has a latest available DilutionScore record of 82/100, categorized as critical dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for CANF, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for CANF?

DilutionWatch tracks 25 SEC filing types for CANF including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect CANF shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For CANF, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for CANF tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for CANF. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

CANF Dilution Risk Score: 82/100 (component-limited)

Score Breakdown

📋 Offering Ability

72

💰 Cash Runway

65

📊Float Risk—

⚠️ Warrant Exposure

90

🔄 Convertible Debt

40

Dilution Forecast

⛈️

Warning

High probability of dilution event

model est. 37%

📜 Warrant Exercise model 60%

• Massive warrant overhang: 2291% of shares outstanding

• Warrant risk score very high (90/100)

💰 Capital Raise model 15%

• Under 12 months cash (7mo)

📉 Score Deterioration model 15%

• Score already CRITICAL (82/100) — events likely imminent

🔔 Track CANF — Get forecast alerts →

Market Data

Market Cap$7.18M

Shares Outstanding2.62M

FloatN/A

Cash$5.53M

Debt$71.0K

Short InterestN/A

Institutional Holdings

QoQ: ↓ 97.9% shares (2026Q1 vs prior)

1 institutional holders · 12.6K shares

#1 MORGAN STANLEY 12.6K shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest66.1K

Days to Cover1.6

% of FloatN/A

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2024-08-08

3 FORM3 2026-04-06

EFFECT EFFECT 2026-04-03

424B3 ATM 2026-04-03

F-3 SHELF 2026-03-31

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual CANF Dilution Snapshot

Can-Fite BioPharma Ltd. (CANF) has a DilutionScore of 82/100, rated Critical dilution risk. Score date: August 28, 2026.

Stored outstanding warrants: 60.0M.
Recent SEC activity tracked for CANF: 3 on 2026-04-06; EFFECT on 2026-04-03; 424B3 on 2026-04-03.
Score coverage note: Float Risk is excluded because public-float data is unavailable.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education

→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

Float Risk is excluded because public-float data is unavailable.

CANF — Can-Fite BioPharma Ltd. Dilution Risk Tracker